The Role of Genetics in IBS

Gastroenterology Clinics of North America

Volumn 40, Issue 1, 2011, Pages 45-67

  Saito, Yuri A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Complex genetic disease; Gene; Genetics; Irritable bowel syndrome

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CATECHOL METHYLTRANSFERASE; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; SEROTONIN 2A RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.3; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; ASTHMA; AUTOSOMAL DOMINANT INHERITANCE; CONSTIPATION; DEFECATION URGENCY; DISTRESS SYNDROME; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FAMILY STRESS; FIBROMYALGIA; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEARTBURN; HERITABILITY; HUMAN; ILLNESS BEHAVIOR; IRRITABLE COLON; LOOSE FECES; PATHOGENESIS; RECESSIVE INHERITANCE; SEXUAL ABUSE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIZATION; VERBAL HOSTILITY;

EID: 79951568144     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2010.12.011     Document Type: Review

References (89)

1. El-Serag H.B., Olden K., Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002, 16(6):1171-1185.
2. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8(6):458-466.
3. Pace F., Zuin G., Di Giacomo S., et al. Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain. World J Gastroenterol 2006, 12(24):3874-3877.
4. Whorwell P.J., McCallum M., Creed F.H., et al. Non-colonic features of irritable bowel syndrome. Gut 1986, 27(1):37-40.
5. Bellentani S., Baldoni P., Petrella S., et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 1990, 7(4):307-312.
6. Saito Y.A., Zimmerman J.M., Harmsen W.S., et al. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil 2008, 20:790-797.
7. Saito Y.A., Petersen G.M., Larson J.J., et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol 2010, 105(4):833-841.
8. Buonavolonta R., Coccorullo P., Turco R., et al. Familial aggregation in children affected by functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2010, 50(5):500-505.
9. Saito-Loftus Y., Larson J., Atkinson E., et al. Irritable bowel syndrome (IBS) is not a major gene, Mendelian disorder. Am J Gastroenterol 2008, 103(Suppl S):S472.
10. Saito Y., Zimmerman J., Almazar-Elder A., et al. Clinical characteristics of familial irritable bowel syndrome (IBS) differ from sporadic IBS. Gastroenterology 2008, 134(4 Suppl 1):A-30.
11. Kanazawa M., Endo Y., Whitehead W.E., et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci 2004, 49(6):1046-1053.
12. Morris-Yates A., Talley N.J., Boyce P.M., et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998, 93(8):1311-1317.
13. Levy R.L., Jones K.R., Whitehead W.E., et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001, 121(4):799-804.
14. Lembo A., Zaman M., Jones M., et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007, 25(11):1343-1350.
15. Mohammed I., Cherkas L.F., Riley S.A., et al. Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol 2005, 100(6):1340-1344.
16. Svedberg P., Johansson S., Wallander M.A., et al. Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study. Aliment Pharmacol Ther 2002, 16(5):975-983.
17. Anand K., Runeson B., Jacobson B. Gastric suction at birth associated with long-term risk for functional intestinal disorders in later life. J Pediatr 2004, 144(4):449-454.
18. Barreau F., Ferrier L., Fioramonti J., et al. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res 2007, 62(3):240-245.
19. Howell S., Talley N., Quine S., et al. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004, 99(8):1572-1578.
20. Mendall M., Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998, 10(1):59-62.
21. Gray G.C., Reed R.J., Kaiser K.S., et al. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 2002, 155(11):1033-1044.
22. Gasbarrini A., Lauritano E.C., Garcovich M., et al. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. Eur Rev Med Pharmacol Sci 2008, 12(Suppl 1):111-117.
23. Drossman D.A. Irritable bowel syndrome and sexual/physical abuse history. Eur J Gastroenterol Hepatol 1997, 9(4):327-330.
24. Walker E.A., Katon W.J., Roy-Byrne P.P., et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993, 150(10):1502-1506.
25. Talley N.J., Fett S.L., Zinsmeister A.R., et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994, 107(4):1040-1049.
26. Talley N.J., Fett S.L., Zinsmeister A.R. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol 1995, 90(3):366-371.
27. Heitkemper M., Jarrett M., Taylor P., et al. Effect of sexual and physical abuse on symptom experiences in women with irritable bowel syndrome. Nurs Res 2001, 50(1):15-23.
28. Whitehead W.E., Crowell M.D., Davidoff A.L., et al. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Dig Dis Sci 1997, 42(4):796-804.
29. Ringel Y., Whitehead W.E., Toner B.B., et al. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut 2004, 53(6):838-842.
30. Talley N.J., Boyce P.M., Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998, 42(1):47-53.
31. Dube S.R., Felitti V.J., Dong M., et al. The impact of adverse childhood experiences on health problems: evidence from four birth cohorts dating back to 1900. Prev Med 2003, 37(3):268-277.
32. Videlock E.J., Adeyemo M., Licudine A., et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009, 137(6):1954-1962.
33. Whitehead W., Winget C., Fedoravicius A., et al. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982, 27(3):202-208.
34. Lowman B., Drossman D., Cramer E., et al. Recollection of childhood events in adults with irritable bowel syndrome. J Clin Gastroenterol 1987, 9(3):324-330.
35. Levy R., Whitehead W., Walker L., et al. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol 2004, 99(12):2442-2451.
36. Villani A., Saito Y., Lemire M., et al. Validation of genetic risk factors for post-infectious irritable bowel syndrome (IBS) in patients with sporadic IBS. Gastroenterology 2009, 136(5 Suppl 1):289.
37. Chang J., Locke G., Talley N., et al. Comparison of lactase variant MCM6-13910C>T testing and self-report of dairy sensitivity in patients with irritable bowel syndrome. Am J Gastroenterol 2010, 105(Suppl 1):S499.
38. Sullivan G., Jenkins P.L., Blewett A.E. Irritable bowel syndrome and family history of psychiatric disorder: a preliminary study. Gen Hosp Psychiatry 1995, 17(1):43-46.
39. Woodman C.L., Breen K., Noyes R., et al. The relationship between irritable bowel syndrome and psychiatric illness. A family study. Psychosomatics 1998, 39(1):45-54.
40. Whitehead W.E., Bosmajian L., Zonderman A.B., et al. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988, 95(3):709-714.
41. Saito Y., Larson J., Atkinson E., et al. A candidate gene association study of functional "psychiatric" polymorphisms in irritable bowel syndrome. Gastroenterology 2010, 138(5 Suppl 1):348.
42. 4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009, 104:1831-1843.
43. Tack J., Muller-Lissner S., Bytzer P., et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 2005, 54(12):1707-1713.
44. Van Kerkhoven L.A., Laheij R.J., Jansen J.B. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26(7):979-986.
45. Saito Y., Larson J., Atkinson E., et al. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene environment interactions in irritable bowel syndrome. Gastroenterology 2009, 136(5 Suppl 1):289.
46. Kapeller J., Houghton L., Monnikes H., et al. First evidence for an association of functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008, 17(19):2967-2977.
47. Niesler B., Frank B., Kapeller J., et al. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 2003, 310:101-111.
48. Fukudo S., Ozaki N., Watanabe S., et al. Impact of serotonin-3 receptor gene polymorphism on brain activation by rectal distention in human. Gastroenterology 2009, 136(5 Suppl 1):A-170.
49. Saito Y., Larson J., Atkinson E., et al. A serotonin-pathway candidate gene association study of irritable bowel syndrome (IBS). Gastrenterology 2010, 138(5 Suppl 1):348.
50. Villani A.-C., Lemire M., Thabane M., et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010, 138(4):1502-1513.
51. Gonsalkorale W.M., Perrey C., Pravica V., et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?. Gut 2003, 52(1):91-93.
52. van der Veek P.P., van den Berg M., de Kroon Y.E., et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005, 100(11):2510-2516.
53. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122(4):1140-1156.
54. Dickinson D., Elvevag B. Genes, cognition and brain through a COMT lens. Neuroscience 2009, 164(1):72-87.
55. Domschke K., Deckert J., O'Donovan M.C., et al. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(5):667-673.
56. Hosak L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 2007, 22(5):276-281.
57. Way B.M., Lieberman M.D. Is there a genetic contribution to cultural differences? Collectivism, individualism and genetic markers of social sensitivity. Soc Cogn Affect Neurosci 2010, 5(2-3):203-211.
58. Tan E.C., Lim E.C., Teo Y.Y., et al. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 2009, 5:32.
59. Frielingsdorf H., Bath K.G., Soliman F., et al. Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci 2010, 1208:150-157.
60. Cirulli F., Berry A., Bonsignore L.T., et al. Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci Biobehav Rev 2010, 34(6):808-820.
61. Fan J., Sklar P. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp 2008, 289:60-72. [discussion: 72-3, 87-93].
62. Gottesman, Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160(4):636-645.
63. Grudell A.B., Camilleri M., Carlson P., et al. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 2008, 20(3):213-219.
64. Camilleri M., Busciglio I., Carlson P., et al. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2008, 295(2):G219-G225.
65. Camilleri M., Carlson P., McKinzie S., et al. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol 2008, 294(1):G13-G19.
66. Camilleri M., Carlson P., Zinsmeister A.R., et al. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology 2010, 138(1):98-107. e104.
67. Cremonini F., Camilleri M., McKinzie S., et al. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol 2005, 100(3):652-663.
68. Rao A.S., Wong B.S., Camilleri M., et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 2010, 139(5):1549-1558. 1558 e1541.
69. Wong B., Camilleri M., Carlson P., et al. Klotho-beta gene polymorphism is associated with colonic transit in health and lower functional gastrointestinal disorders. Gastroenterology 2010, 138(5 Suppl 1):S-624.
70. Fukudo S., Kanazawa M., Mizuno T., et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 2009, 47(3):946-951.
71. Labus J.S., Mayer E.A., Hamaguchi T., et al. 5-HTTLPR gene polymorphism modulates activity and connectivity within an emotional arousal network of healthy control subjects during visceral pain. Gastroenterology 2008, 134(4 Suppl 1):A121.
72. Truong T., Kilpatrick L., Naliboff B., et al. COMT genetic polymorphism is associated with alterations in attentional processing in patients with IBS and other functional pain syndromes. Gastrenterology 2009, 136(Suppl 1):A-74.
73. Pata C., Erdal M.E., Derici E., et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002, 97(7):1780-1784.
74. Niesler B., Kapeller J., Fell C., et al. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. Eur J Gastroenterol Hepatol 2010, 22(7):856-861.
75. Kohen R., Jarrett M., Cain K., et al. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci 2009, 54(12):2663-2670.
76. Pata C., Erdal E., Yazc K., et al. Association of the -1438 G/A and 102 T/C polymorphism of the 5-HT2A receptor gene with irritable bowel syndrome 5-HT2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol 2004, 38(7):561-566.
77. Kapeller J., Houghton L., Walstab J., et al. A coding variant in the serotonin receptor 3C subunit is associated with diarrhea-predominant irritable bowel syndrome. Gastroenterology 2009, 136(5 Suppl 1):A-155-A-156.
78. Barkhordari E., Rezaei N., Mahmoudi M., et al. T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation 2010, 33(5):281-286.
79. Barkhordari E., Rezaei N., Ansaripour B., et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010, 30(1):74-79.
80. Santhosh S., Dutta A., Samuel P., et al. Cytokine gene polymorphisms in irritable bowel syndrome in Indian population-a pilot case control study. Trop Gastroenterol 2010, 31(1):30-33.
81. Kim H.J., Camilleri M., Carlson P.J., et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004, 53(6):829-837.
82. Sikander A., Rana S.V., Sharma S.K., et al. Association of alpha 2A adrenergic receptor gene (ADRα2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis. Clin Chim Acta 2010, 411(1-2):59-63.
83. Park S., Rew J., Lee S., et al. Association of CCK(1) receptor gene polymorphisms and irritable bowel syndrome in Korean. J Neurogastroenterol Motil 2010, 16(1):71-76.
84. Colucci R., Ghisu N., Bellini M., et al. Analysis of cholecystokinin type 1 receptor gene polymorphisms in patients with irritable bowel syndrome. Gastroenterology 2009, 136(5 Suppl 1):A-225.
85. Park J., Choi M., Cho Y., et al. Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. J Clin Gastroenterol 2011, 45(1):45-49.
86. Holtmann G., Siffert W., Haag S., et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004, 126(4):971-979.
87. Andresen V., Camilleri M., Kim H.J., et al. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?. Gastroenterology 2006, 130(7):1985-1994.
88. Saito Y.A., Locke G.R., Zimmerman J.M., et al. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2007, 19(6):465-470.
89. Saito Y.A., Strege P.R., Tester D.J., et al. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol 2009, 296(2):G211-G218.